Open-label randomized comparative study of cefepime vs. meropenem in adults with severe community-acquired pneumonia

Trial Profile

Open-label randomized comparative study of cefepime vs. meropenem in adults with severe community-acquired pneumonia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 May 2016

At a glance

  • Drugs Cefepime (Primary) ; Meropenem (Primary) ; Azithromycin; Erythromycin
  • Indications Bacterial infections; Community-acquired pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 Sep 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.
    • 04 Mar 2013 Planned End Date 30 Oct 2013 added as reported by University Hospital Medical Information Network - Japan.
    • 13 Apr 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top